PA
PAVM icon

Parallel Advisors’s PAVmed PAVM Stock Holding History

Parallel Advisors’s Portfolio PAVM Stock Details PAVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-3
Closed -$49 – 3625
2024
Q4 		$49 Hold
3
– – ﹤0.01% 3483
2024
Q3 		$96 Hold
3
– – ﹤0.01% 3339
2024
Q2 		$64 Buy
+3
New +$150 ﹤0.01% 3264
2021
Q4 		– Sell
-1
Closed -$2.17K – 3234
2021
Q3 		$2K Buy
+1
New +$3.15K ﹤0.01% 2713

Other funds holding PAVM

First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors Raleigh, North Carolina $57.3B AUM 18.32% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
OWP
Obermeyer Wealth Partners Aspen, Colorado $2.17B AUM 19.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Parallel Advisors's PAVM Position: Q1 2025 in Review

Parallel Advisors sold out of PAVmed (PAVM) in Q1 2025, closing a stake of 3 shares — an estimated $49 sold.

Parallel Advisors first reported a position in PAVM in Q3 2021 and held it in 4 quarters. The position peaked at $2K in Q3 2021. 29 funds tracked by Wall St. Rank hold PAVM as of Q1 2025.

  • Parallel Advisors reported no remaining PAVmed position as of Q1 2025 after selling out during the quarter.
  • Parallel Advisors sold 3 PAVmed shares in Q1 2025, an estimated $49.
  • Parallel Advisors first reported a position in PAVmed in Q3 2021 and held it in 4 quarters.
  • Parallel Advisors's PAVmed position peaked at $2K in Q3 2021.
  • 29 funds tracked by Wall St. Rank held PAVmed as of Q1 2025.

Based on Parallel Advisors's 13F filing for Q1 2025, filed 8 Apr 2025.